rs2836430

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_182918.4(ERG):​c.18+20733A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.116 in 152,224 control chromosomes in the GnomAD database, including 1,126 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.12 ( 1126 hom., cov: 32)

Consequence

ERG
NM_182918.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.158

Publications

1 publications found
Variant links:
Genes affected
ERG (HGNC:3446): (ETS transcription factor ERG) This gene encodes a member of the erythroblast transformation-specific (ETS) family of transcriptions factors. All members of this family are key regulators of embryonic development, cell proliferation, differentiation, angiogenesis, inflammation, and apoptosis. The protein encoded by this gene is mainly expressed in the nucleus. It contains an ETS DNA-binding domain and a PNT (pointed) domain which is implicated in the self-association of chimeric oncoproteins. This protein is required for platelet adhesion to the subendothelium, inducing vascular cell remodeling. It also regulates hematopoesis, and the differentiation and maturation of megakaryocytic cells. This gene is involved in chromosomal translocations, resulting in different fusion gene products, such as TMPSSR2-ERG and NDRG1-ERG in prostate cancer, EWS-ERG in Ewing's sarcoma and FUS-ERG in acute myeloid leukemia. More than two dozens of transcript variants generated from combinatorial usage of three alternative promoters and multiple alternative splicing events have been reported, but the full-length nature of many of these variants has not been determined. [provided by RefSeq, Apr 2014]
ERG Gene-Disease associations (from GenCC):
  • lymphatic malformation 14
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.251 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_182918.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ERG
NM_182918.4
MANE Select
c.18+20733A>C
intron
N/ANP_891548.1P11308-4
ERG
NM_001136154.1
c.40-32009A>C
intron
N/ANP_001129626.1P11308-3
ERG
NM_001243428.1
c.40-32009A>C
intron
N/ANP_001230357.1P11308-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ERG
ENST00000288319.12
TSL:1 MANE Select
c.18+20733A>C
intron
N/AENSP00000288319.7P11308-4
ERG
ENST00000398919.6
TSL:1
c.40-32009A>C
intron
N/AENSP00000381891.2P11308-3
ERG
ENST00000398905.5
TSL:1
c.18+20733A>C
intron
N/AENSP00000381877.1B5MDW0

Frequencies

GnomAD3 genomes
AF:
0.116
AC:
17635
AN:
152106
Hom.:
1120
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0760
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.136
Gnomad ASJ
AF:
0.0829
Gnomad EAS
AF:
0.262
Gnomad SAS
AF:
0.132
Gnomad FIN
AF:
0.0922
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.131
Gnomad OTH
AF:
0.111
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.116
AC:
17641
AN:
152224
Hom.:
1126
Cov.:
32
AF XY:
0.115
AC XY:
8541
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.0761
AC:
3163
AN:
41556
American (AMR)
AF:
0.136
AC:
2075
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0829
AC:
287
AN:
3460
East Asian (EAS)
AF:
0.262
AC:
1356
AN:
5172
South Asian (SAS)
AF:
0.131
AC:
633
AN:
4826
European-Finnish (FIN)
AF:
0.0922
AC:
977
AN:
10596
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.131
AC:
8888
AN:
67994
Other (OTH)
AF:
0.110
AC:
233
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
820
1640
2459
3279
4099
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
202
404
606
808
1010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.125
Hom.:
932
Bravo
AF:
0.118
Asia WGS
AF:
0.166
AC:
577
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.77
DANN
Benign
0.76
PhyloP100
-0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2836430; hg19: chr21-39849553; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.